HSK31679
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for HSK31679, covering 2024-04-09 to 2026-02-11. Get the full timeline:
Most recent: Clinical Trial Update: To Evaluate the Efficacy and Safety of HSK31679 in Chinese Patients With Non-Alcoholic Steatohepatitis (NASH) . [Phase 2]